Annual Accounts Receivable
$71.00 K
+$69.00 K+3450.00%
December 31, 2023
Summary
- As of February 7, 2025, DMAC annual accounts receivable is $71.00 thousand, with the most recent change of +$69.00 thousand (+3450.00%) on December 31, 2023.
- During the last 3 years, DMAC annual accounts receivable has risen by +$54.00 thousand (+317.65%).
- DMAC annual accounts receivable is now -43.70% below its all-time high of $126.10 thousand, reached on December 31, 2010.
Performance
DMAC Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$2000.00
-$2000.00-50.00%
September 30, 2024
Summary
- As of February 7, 2025, DMAC quarterly accounts receivable is $2000.00, with the most recent change of -$2000.00 (-50.00%) on September 30, 2024.
- Over the past year, DMAC quarterly accounts receivable has increased by +$1000.00 (+100.00%).
- DMAC quarterly accounts receivable is now -99.56% below its all-time high of $452.40 thousand, reached on September 30, 2018.
Performance
DMAC Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
DMAC Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3450.0% | +100.0% |
| 3 y3 years | +317.6% | +100.0% |
| 5 y5 years | +195.8% | +100.0% |
DMAC Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | -97.2% | -100.0% |
| 5 y | 5-year | at high | -100.0% | -97.2% | -100.0% |
| alltime | all time | -43.7% | -100.0% | -99.6% | -100.0% |
DiaMedica Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2000.00(-50.0%) |
| Jun 2024 | - | $4000.00(-50.0%) |
| Mar 2024 | - | $8000.00(-88.7%) |
| Dec 2023 | $71.00 K(+3450.0%) | $71.00 K(+7000.0%) |
| Sep 2023 | - | $1000.00(-50.0%) |
| Jun 2023 | - | $2000.00(0.0%) |
| Mar 2023 | - | $2000.00(0.0%) |
| Dec 2022 | $2000.00(>+9900.0%) | $2000.00(0.0%) |
| Mar 2022 | - | $2000.00(>+9900.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2021 | - | $0.00(-100.0%) |
| Jun 2021 | - | $16.00 K(-63.6%) |
| Mar 2021 | - | $44.00 K(+158.8%) |
| Dec 2020 | $17.00 K(0.0%) | $17.00 K(+112.5%) |
| Sep 2020 | - | $8000.00(-55.6%) |
| Jun 2020 | - | $18.00 K(-53.8%) |
| Mar 2020 | - | $39.00 K(+129.4%) |
| Dec 2019 | $17.00 K(-29.2%) | $17.00 K(-32.0%) |
| Sep 2019 | - | $25.00 K(-19.4%) |
| Jun 2019 | - | $31.00 K(-34.0%) |
| Mar 2019 | - | $47.00 K(+95.8%) |
| Dec 2018 | $24.00 K(-70.0%) | $24.00 K(-94.7%) |
| Sep 2018 | - | $452.40 K(+465.5%) |
| Dec 2017 | $80.00 K(>+9900.0%) | $80.00 K(>+9900.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(-100.0%) |
| Mar 2016 | - | $400.00(0.0%) |
| Dec 2015 | $400.00(-95.2%) | $400.00(>+9900.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(-100.0%) |
| Mar 2015 | - | $3700.00(-56.0%) |
| Dec 2014 | $8400.00 | $8400.00(+1100.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2014 | - | $700.00(0.0%) |
| Jun 2014 | - | $700.00(0.0%) |
| Mar 2014 | - | $700.00(0.0%) |
| Dec 2013 | $700.00(-75.0%) | $700.00(-70.8%) |
| Sep 2013 | - | $2400.00(+41.2%) |
| Jun 2013 | - | $1700.00(-70.2%) |
| Mar 2013 | - | $5700.00(+103.6%) |
| Dec 2012 | $2800.00(-57.6%) | $2800.00(-39.1%) |
| Sep 2012 | - | $4600.00(+76.9%) |
| Jun 2012 | - | $2600.00(-96.5%) |
| Mar 2012 | - | $73.90 K(+1019.7%) |
| Dec 2011 | $6600.00(-94.8%) | $6600.00(+26.9%) |
| Mar 2011 | - | $5200.00(-95.9%) |
| Dec 2010 | $126.10 K(+693.1%) | $126.10 K(+5.9%) |
| Sep 2010 | - | $119.10 K(+141.1%) |
| Jun 2010 | - | $49.40 K(-75.1%) |
| Mar 2010 | - | $198.30 K(+1147.2%) |
| Dec 2009 | $15.90 K(-48.9%) | $15.90 K(-79.0%) |
| Sep 2009 | - | $75.70 K(+99.7%) |
| Jun 2009 | - | $37.90 K(+116.6%) |
| Mar 2009 | - | $17.50 K(-43.7%) |
| Dec 2008 | $31.10 K(-67.4%) | $31.10 K(-67.1%) |
| Sep 2008 | - | $94.40 K(+35.1%) |
| Jun 2008 | - | $69.90 K(+81.6%) |
| Mar 2008 | - | $38.50 K(-59.7%) |
| Dec 2007 | $95.50 K(+67.3%) | $95.50 K(-47.6%) |
| Sep 2007 | - | $182.40 K(+72.9%) |
| Jun 2007 | - | $105.50 K(-29.6%) |
| Mar 2007 | - | $149.90 K(+162.5%) |
| Dec 2006 | $57.10 K(+89.1%) | $57.10 K(+117.1%) |
| Sep 2006 | - | $26.30 K(-12.9%) |
| Dec 2005 | $30.20 K(+51.0%) | $30.20 K |
| Dec 2004 | $20.00 K | - |
FAQ
- What is DiaMedica Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics annual accounts receivable year-on-year change?
- What is DiaMedica Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for DiaMedica Therapeutics?
- What is DiaMedica Therapeutics quarterly accounts receivable year-on-year change?
What is DiaMedica Therapeutics annual accounts receivable?
The current annual accounts receivable of DMAC is $71.00 K
What is the all time high annual accounts receivable for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high annual accounts receivable is $126.10 K
What is DiaMedica Therapeutics annual accounts receivable year-on-year change?
Over the past year, DMAC annual accounts receivable has changed by +$69.00 K (+3450.00%)
What is DiaMedica Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of DMAC is $2000.00
What is the all time high quarterly accounts receivable for DiaMedica Therapeutics?
DiaMedica Therapeutics all-time high quarterly accounts receivable is $452.40 K
What is DiaMedica Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, DMAC quarterly accounts receivable has changed by +$1000.00 (+100.00%)